COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin, received more than 1000 applications
AIIMS Delhi has received an overwhelming response for COVID Human Trials Phase 1 participation. Over 1000 volunteers have sent a request for being part of trials. 100 volunteers to be given the vaccine in the first phase.
READ MORE:
Other Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
USV | Take heart: Steering preventive strategies for charting a journey towards cardiac wellness
Beat Diabetes With Lifestyle Modification
Serum to double investment in Biocon's unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw
India is stepping up genome sequencing of COVID 19 positive samples amid growing outbreaks in China, Japan and South Korea
